Optimal intravesical dosage of thio-tepa in the prophylaxis of recurrent bladder papillomatosis.
D000284:Administration, Oral; D003558:Cystoscopy; D006801:Humans; D007267:Injections; D007970:Leukopenia / Q000150:complications; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D010212:Papilloma / Q000188:drug therapy*; D013852:Thiotepa / Q000008:administration & dosage* / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000150:complications; D001745:Urinary Bladder Diseases / Q000188:drug therapy*
D013852:Thiotepa